Literature DB >> 9534977

Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis.

B Kahl1, M Herrmann, A S Everding, H G Koch, K Becker, E Harms, R A Proctor, G Peters.   

Abstract

In a 34-month prospective study to determine the prevalence of Staphylococcus aureus small colony variants (SCVs) in cystic fibrosis (CF) patients, S. aureus SCVs or SCVs plus normal S. aureus were recovered from 26 of 78 patients; 27 patients harbored only normal S. aureus. By pulsed-field gel electrophoresis, clonal identity was demonstrated of SCV and normal strains isolated at the same time and of multiple S. aureus SCV and normal strains in consecutive specimens from individual patients. All S. aureus SCVs were resistant to antifolate antibiotics, while the corresponding parent strains were susceptible, and in 11 of 12 SCV/normal pairs, gentamicin was less active against S. aureus with the SCV phenotype than against the normal isolate. Analysis of the underlying auxotrophism of SCVs revealed hemin, thymidine, and/or menadione dependencies. Thus, S. aureus SCVs are highly prevalent in respiratory secretions of CF patients, persist over extended periods, and may contribute to S. aureus persistence in CF patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534977     DOI: 10.1086/515238

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  135 in total

1.  Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex.

Authors:  S Häussler; C Lehmann; C Breselge; M Rohde; M Classen; B Tümmler; P Vandamme; I Steinmetz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-28       Impact factor: 3.267

2.  Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy.

Authors:  H Adler; A Widmer; R Frei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

3.  Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.

Authors:  Anne-Laure Prunier; Brigitte Malbruny; Didier Tandé; Bertrand Picard; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 4.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

5.  Metabolically deficient methicillin-resistant Staphylococcus aureus as cause of chronic post-thoracotomy sternal wound infection.

Authors:  A Roggenkamp; A Haas; W Eder; E Kreuzer; H Hoffmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

6.  Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection.

Authors:  Awele Maduka-Ezeh; Maria Teresa Seville; Shimon Kusne; Holenarasipur R Vikram; Janis E Blair; Kerryl Greenwood-Quaintance; Francisco Arabia; Robin Patel
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

7.  Enhanced post-stationary-phase survival of a clinical thymidine-dependent small-colony variant of Staphylococcus aureus results from lack of a functional tricarboxylic acid cycle.

Authors:  Indranil Chatterjee; Mathias Herrmann; Richard A Proctor; Georg Peters; Barbara C Kahl
Journal:  J Bacteriol       Date:  2007-01-26       Impact factor: 3.490

8.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

9.  Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones.

Authors:  Xiao-Su Pan; Penelope J Hamlyn; Raquel Talens-Visconti; Fabiana L Alovero; Ruben H Manzo; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Two diarylurea electron transport inhibitors reduce Staphylococcus aureus hemolytic activity and protect cultured endothelial cells from lysis.

Authors:  R A Proctor; S C Dalal; B Kahl; D Brar; G Peters; W W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.